Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Progenics elects new chairman

This article was originally published in Scrip

Executive Summary

Progenics Pharmaceuticals (US) has elected board member Peter Crowley as chairman of the board. He replaces Kurt Briner, who is stepping down at the end of his term while remaining as a director. Mr Crowley has more than 20 years' experience in healthcare finance as a senior investment banker; he recently retired from a 23-year career at CIBC World Markets, where he had served head of healthcare investment banking since 1995.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC009138

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel